2784 Stock Overview
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 2784 from our risk checks.
Alfresa Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,235.00 |
| 52 Week High | JP¥2,643.50 |
| 52 Week Low | JP¥1,906.00 |
| Beta | 0.051 |
| 1 Month Change | -1.76% |
| 3 Month Change | -7.49% |
| 1 Year Change | 15.56% |
| 3 Year Change | 14.38% |
| 5 Year Change | -27.79% |
| Change since IPO | 144.93% |
Recent News & Updates
Is There An Opportunity With Alfresa Holdings Corporation's (TSE:2784) 32% Undervaluation?
Apr 19
Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 12Alfresa Holdings' (TSE:2784) Dividend Will Be Increased To ¥35.00
Feb 27Shareholder Returns
| 2784 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 2.1% | 1.2% | 1.8% |
| 1Y | 15.6% | 4.1% | 31.0% |
Return vs Industry: 2784 exceeded the JP Healthcare industry which returned 2.8% over the past year.
Return vs Market: 2784 underperformed the JP Market which returned 27.9% over the past year.
Price Volatility
| 2784 volatility | |
|---|---|
| 2784 Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 2784 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2784's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 11,772 | Ryuji Arakawa | www.alfresa.com |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.
Alfresa Holdings Corporation Fundamentals Summary
| 2784 fundamental statistics | |
|---|---|
| Market cap | JP¥417.65b |
| Earnings (TTM) | JP¥31.84b |
| Revenue (TTM) | JP¥2.83t |
13.1x
P/E Ratio0.1x
P/S RatioIs 2784 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2784 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.83t |
| Cost of Revenue | JP¥2.62t |
| Gross Profit | JP¥204.66b |
| Other Expenses | JP¥172.82b |
| Earnings | JP¥31.84b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 170.36 |
| Gross Margin | 7.24% |
| Net Profit Margin | 1.13% |
| Debt/Equity Ratio | 6.5% |
How did 2784 perform over the long term?
See historical performance and comparison